Innova Captab Limited (INNOVACAP) - Total Assets
Based on the latest financial reports, Innova Captab Limited (INNOVACAP) holds total assets worth Rs18.37 Billion INR (≈ $198.71 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Innova Captab Limited to assess how comfortably operating cash covers total debt obligations.
Innova Captab Limited - Total Assets Trend (2018–2026)
This chart illustrates how Innova Captab Limited's total assets have evolved over time, based on quarterly financial data. See INNOVACAP net asset value for net asset value and shareholders' equity analysis.
Innova Captab Limited - Asset Composition Analysis
Current Asset Composition (March 2026)
Innova Captab Limited's total assets of Rs18.37 Billion consist of 50.2% current assets and 49.8% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0.2% |
| Accounts Receivable | Rs4.38 Billion | 23.8% |
| Inventory | Rs2.83 Billion | 15.4% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs14.83 Million | 0.1% |
| Goodwill | Rs166.94 Million | 0.9% |
Asset Composition Trend (2018–2026)
This chart illustrates how Innova Captab Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Innova Captab Limited market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Innova Captab Limited's current assets represent 50.2% of total assets in 2026, a decrease from 60.1% in 2018.
- Cash Position: Cash and equivalents constituted 0.2% of total assets in 2026, up from 0.1% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 23.8% of total assets.
Innova Captab Limited Competitors by Total Assets
Key competitors of Innova Captab Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329
|
China | CN¥11.59 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥10.21 Billion |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
|
China | CN¥17.01 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥13.81 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Zhejiang Tianyu Pharmaceutical Co Ltd
SHE:300702
|
China | CN¥6.56 Billion |
|
Zhejiang Garden Bio-chemical High-tech Co Ltd
SHE:300401
|
China | CN¥5.91 Billion |
|
KPC Pharmaceuticals Inc
SHG:600422
|
China | CN¥12.01 Billion |
Innova Captab Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.87 | 1.99 | 1.16 |
| Quick Ratio | 1.29 | 1.40 | 0.73 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs4.28 Billion | Rs3.50 Billion | Rs531.96 Million |
Innova Captab Limited - Advanced Valuation Insights
This section examines the relationship between Innova Captab Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.58 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 16.3% |
| Total Assets | Rs18.37 Billion |
| Market Capitalization | $606.52 Million USD |
Valuation Analysis
Below Book Valuation: The market values Innova Captab Limited's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Innova Captab Limited's assets grew by 16.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Innova Captab Limited (2018–2026)
The table below shows the annual total assets of Innova Captab Limited from 2018 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs18.37 Billion ≈ $198.71 Million |
+16.26% |
| 2025-03-31 | Rs15.80 Billion ≈ $170.92 Million |
+19.65% |
| 2024-03-31 | Rs13.21 Billion ≈ $142.85 Million |
+29.66% |
| 2023-03-31 | Rs10.19 Billion ≈ $110.17 Million |
+77.02% |
| 2022-03-31 | Rs5.75 Billion ≈ $62.24 Million |
+55.70% |
| 2021-03-31 | Rs3.70 Billion ≈ $39.97 Million |
-2.70% |
| 2020-03-31 | Rs3.80 Billion ≈ $41.08 Million |
+15.61% |
| 2019-03-31 | Rs3.29 Billion ≈ $35.53 Million |
+62.23% |
| 2018-03-31 | Rs2.03 Billion ≈ $21.90 Million |
-- |
About Innova Captab Limited
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhib… Read more